These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32090444)

  • 1. Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis.
    De Martin E; Rayar M; Golse N; Dupeux M; Gelli M; Gnemmi V; Allard MA; Cherqui D; Sa Cunha A; Adam R; Coilly A; Antonini TM; Guettier C; Samuel D; Boudjema K; Boleslawski E; Vibert E
    Liver Transpl; 2020 Jun; 26(6):785-798. PubMed ID: 32090444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
    Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
    Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus liver resection and liver transplantation for small combined hepatocellular-cholangiocarcinoma stratified by tumor size.
    Peng S; Dong SC; Bai DS; Zhang C; Jin SJ; Jiang GQ
    Langenbecks Arch Surg; 2023 Mar; 408(1):119. PubMed ID: 36918430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.
    Ishii T; Ito T; Sumiyoshi S; Ogiso S; Fukumitsu K; Seo S; Taura K; Uemoto S
    World J Surg Oncol; 2020 Dec; 18(1):319. PubMed ID: 33276780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
    Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
    Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors.
    Dageforde LA; Vachharajani N; Tabrizian P; Agopian V; Halazun K; Maynard E; Croome K; Nagorney D; Hong JC; Lee D; Ferrone C; Baker E; Jarnagin W; Hemming A; Schnickel G; Kimura S; Busuttil R; Lindemann J; Florman S; Holzner ML; Srouji R; Najjar M; Yohanathan L; Cheng J; Amin H; Rickert CA; Yang JD; Kim J; Pasko J; Chapman WC; Majella Doyle MB
    J Am Coll Surg; 2021 Apr; 232(4):361-371. PubMed ID: 33316425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
    Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
    Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors of Tumor Recurrence After Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma.
    Park WK; Joshi PK; Lee KW; Lee KB; Hong SK; Yoon KC; Lee JM; Cho JH; Yi NJ; Suh KS
    Transplant Proc; 2020; 52(1):271-275. PubMed ID: 31926744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.
    Sapisochin G; Facciuto M; Rubbia-Brandt L; Marti J; Mehta N; Yao FY; Vibert E; Cherqui D; Grant DR; Hernandez-Alejandro R; Dale CH; Cucchetti A; Pinna A; Hwang S; Lee SG; Agopian VG; Busuttil RW; Rizvi S; Heimbach JK; Montenovo M; Reyes J; Cesaretti M; Soubrane O; Reichman T; Seal J; Kim PT; Klintmalm G; Sposito C; Mazzaferro V; Dutkowski P; Clavien PA; Toso C; Majno P; Kneteman N; Saunders C; Bruix J;
    Hepatology; 2016 Oct; 64(4):1178-88. PubMed ID: 27481548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for intrahepatic cholangiocarcinoma.
    Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
    Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatic tumors: a systematic review.
    Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
    World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.
    Laohawetwanit T; Lerttanatum N; Wanpiyarat N; Manasilp N; Chaiparnich S
    Ann Diagn Pathol; 2021 Aug; 53():151770. PubMed ID: 34147845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?
    Sapisochin G; Rodríguez de Lope C; Gastaca M; Ortiz de Urbina J; Suarez MA; Santoyo J; Castroagudín JF; Varo E; López-Andujar R; Palacios F; Sanchez Antolín G; Perez B; Guiberteau A; Blanco G; González-Diéguez ML; Rodriguez M; Varona MA; Barrera MA; Fundora Y; Ferron JA; Ramos E; Fabregat J; Ciria R; Rufian S; Otero A; Vazquez MA; Pons JA; Parrilla P; Zozaya G; Herrero JI; Charco R; Bruix J
    Am J Transplant; 2014 Mar; 14(3):660-7. PubMed ID: 24410861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
    Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma.
    Zhou YM; Sui CJ; Zhang XF; Li B; Yang JM
    BMC Gastroenterol; 2017 Feb; 17(1):25. PubMed ID: 28183290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification.
    Kim M; Hwang S; Ahn CS; Kim KH; Moon DB; Song GW; Jung DH; Hong SM
    Asian J Surg; 2021 Nov; 44(11):1389-1395. PubMed ID: 33766528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.